Vanhove Geertrui 4
4 · Surrozen, Inc./DE · Filed Dec 19, 2022
Insider Transaction Report
Form 4
Vanhove Geertrui
Chief Medical Officer
Transactions
- Award
Common Stock
2022-12-15$0.41/sh+9,578$3,927→ 32,412 total
Footnotes (1)
- [F1]These shares were acquired under the Surrozen, Inc. 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).